title: Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
authors.affiliation: HTA Unit, ESTAV Toscana Centro, Regional Health Service, Florence, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Messori
authors.forename: V
authors.initials: V
authors.lastname: Fadda
authors.forename: D
authors.initials: D
authors.lastname: Maratea
authors.forename: S
authors.initials: S
authors.lastname: Trippoli
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents
keywords: interferon; meta-analysis; multiple sclerosis; trial sequential analysis